Literature DB >> 7575119

Intrahepatic cholangiocarcinoma. Results of aggressive surgical management.

D Cherqui1, B Tantawi, R Alon, P Piedbois, A Rahmouni, D Dhumeaux, M Julien, P L Fagniez.   

Abstract

OBJECTIVE: To report the results of a deliberately aggressive surgical management in patients with intrahepatic cholangiocarcinoma.
DESIGN: A case series of patients with intrahepatic cholangiocarcinoma.
SETTING: A tertiary care university hospital in a metropolitan area. PATIENTS: From 1989 to 1993, 19 patients with intrahepatic cholangiocarcinoma underwent laparotomy, with a 74% resectability rate (14 liver resections). In addition, two selected patients with a slow-growing tumor underwent orthotopic liver transplantation after limited recurrence following resection in one case and after exploratory laparotomy in the other.
INTERVENTIONS: The 14 liver resections included six right or left hepatectomies and eight extended right or left hepatectomies. Total vascular exclusion of the liver was used in nine cases (64%) and resection of the biliary confluence with reconstruction was used in six cases (43%).
RESULTS: There was one postoperative death (7%). There were four postoperative biliary fistulas (28%). Overall actuarial 1- and 2-year survival rates were 58% and 32%, respectively. The 1- and 2-year survival rates were 100% after curative resection (no lymph node invasion, clearance margin of < or = 1 cm, and solitary tumor [five cases]) and 48% and 10% after palliative resection. Median survival was 14 months for the whole series and 27 and 9 months following curative and palliative resections, respectively. The two liver transplant recipients are alive and free of disease at 25 and 31 months.
CONCLUSION: These results support aggressive surgical management in patients with intrahepatic cholangiocarcinoma, including complex liver resection procedures and selective use of orthotopic liver transplantation.

Entities:  

Mesh:

Year:  1995        PMID: 7575119     DOI: 10.1001/archsurg.1995.01430100051011

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  17 in total

1.  Hepatic vascular exclusion with preservation of the caval flow for liver resections.

Authors:  D Cherqui; B Malassagne; P I Colau; F Brunetti; N Rotman; P L Fagniez
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

2.  Outcomes following resection of intrahepatic cholangiocarcinoma.

Authors:  Parissa Tabrizian; Ghalib Jibara; Jaclyn F Hechtman; Bernardo Franssen; Daniel M Labow; Myron E Schwartz; Swan N Thung; Umut Sarpel
Journal:  HPB (Oxford)       Date:  2014-11-14       Impact factor: 3.647

3.  Factors affecting survival after resection of intrahepatic cholangiocarcinoma.

Authors:  Sae Murakami; Tetsuo Ajiki; Taro Okazaki; Kimihiko Ueno; Masahiro Kido; Ippei Matsumoto; Takumi Fukumoto; Yonson Ku
Journal:  Surg Today       Date:  2014-01-23       Impact factor: 2.549

Review 4.  Monitoring outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.

Authors:  Amir A Rahnemai-Azar; Pallavi Pandey; Ihab Kamel; Timothy M Pawlik
Journal:  Hepat Oncol       Date:  2017-01-20

5.  Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review.

Authors:  Ming Chi; Kaidi Mikhitarian; Chanjuan Shi; Laura W Goff
Journal:  Gastrointest Cancer Res       Date:  2012-11

Review 6.  Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  J Hepatol       Date:  2006-09-25       Impact factor: 25.083

7.  Intrahepatic cholangiocarcinoma: prognostic factors after liver resection.

Authors:  Gennaro Nuzzo; Felice Giuliante; Francesco Ardito; Agostino Maria De Rose; Maria Vellone; Gennaro Clemente; Carlo Chiarla; Ivo Giovannini
Journal:  Updates Surg       Date:  2010-08

8.  Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Authors:  Alfredo Guglielmi; Andrea Ruzzenente; Tommaso Campagnaro; Silvia Pachera; Alessandro Valdegamberi; Paola Nicoli; Alessandro Cappellani; Giulio Malfermoni; Calogero Iacono
Journal:  World J Surg       Date:  2009-06       Impact factor: 3.352

9.  Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma.

Authors:  Shohachi Suzuki; Takanori Sakaguchi; Yoshihiro Yokoi; Kazuya Okamoto; Kiyotaka Kurachi; Yasuo Tsuchiya; Takuya Okumura; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

10.  R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis-related analysis.

Authors:  Georgios C Sotiropoulos; Maximilian Bockhorn; George Sgourakis; Eirini I Brokalaki; Ernesto P Molmenti; Markus Neuhäuser; Arnold Radtke; Jeremias Wohlschlaeger; Hideo A Baba; Christoph E Broelsch; Hauke Lang
Journal:  Dig Dis Sci       Date:  2008-08-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.